Lv71
5008 积分 2023-04-15 加入
HER-2 directed therapies across gastrointestinal tract cancers – A new frontier
3小时前
已完结
Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: a systematic review and Bayesian network meta-analysis
3天前
已完结
POS0017 Bispecific T Cell-Engaging Antibodies to Target TRBV9+ Autoreactive T Cells in Axial Spondyloarthritis
12天前
已关闭
An efficient route to human bispecific IgG
1个月前
已完结
‘Knobs-into-holes’ engineering of antibody CH3 domains for heavy chain heterodimerization
1个月前
已完结
Discovery and Evaluation of TLR-Targeted Immune Agonists
1个月前
已完结
Antibody disulfide bond reduction and recovery during biopharmaceutical process development—A review
1个月前
已完结
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
2个月前
已完结
The antibody–drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial
2个月前
已完结
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer
2个月前
已完结
皖公网安备34019202002308
